Cade Hildreth, Founder: As the 1ST and ONLY market research firm to specialize in the #stemcell industry, BioInformant has been cited by WSJ, Xconomy, & Vogue.
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media - https://t.co/BQiIcMx0iE
@FUJIFILMBiosci@NextCellPharma
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (#iPSC) -
https://t.co/lxKlfXJK9Z
Congrats to the @pluristyx & @QkineBio teams on continuing to advance the iPSC field forward!
Cell-Easy Launches an iPSC-Derived Beta Cell Program to Tackle Scale-Up Challenges - Backed by a €12M Bpifrance grant, the program builds a GMP-compatible manufacturing platform for iPSC-derived cell therapies
https://t.co/11BykAwF2I
Exciting news for MSC innovation: @RoosterBio and MineBio Life Sciences Partner to Expand Access to Scalable, High Quality MSC and Exosome Bioprocessing Solutions in China - https://t.co/uBHPPpdcfE
Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases - https://t.co/LNXPbOLa0T
@Catalent_
Gameto Licenses Foundational Meiosis IP from Harvard to Advance Human Ovary-in-a-Dish Platform - https://t.co/AiLZWa06ek
@GametoGen@harvardmed@wyssinstitute
Longevity Medical Institute® Publishes Systematic Review of Stem Cell Safety Based on Landmark Human Clinical Trials - https://t.co/umil22SfE9 @Longevity_Cabo
Congrats to the @_REPROCELL team on launching its new StemEdit Platform, a comprehensive gene editing platform for iPSCs & newly engineered iPSC lines enabled by OpenCRISPR-1™, an AI-designed genome editing system.
Read more: https://t.co/mxopvmpbRi
#ipscells#geneediting#ai
Longevity Medical Institute® Physicians and Scientists Publish Peer-Reviewed Research on Stem Cell Therapies for Diabetic Foot Ulcers - https://t.co/AVcQhcQuua
Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - https://t.co/TrMnnHl8Dz
@cytonome
Longevity Medical Institute® Opens Federally Licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory in Los Cabos - https://t.co/vXSOWemEQu